<bill session="115" type="s" number="3519" updated="2023-01-11T13:41:18Z">
  <state datetime="2018-09-27">REFERRED</state>
  <status>
    <introduced datetime="2018-09-27"/>
  </status>
  <introduced datetime="2018-09-27"/>
  <titles>
    <title type="display">MODERN Labeling Act</title>
    <title type="official" as="introduced">A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.</title>
    <title type="short" as="introduced">Making Objective Drug Evidence Revisions for New Labeling Act</title>
    <title type="short" as="introduced">MODERN Labeling Act</title>
  </titles>
  <sponsor bioguide_id="H000338"/>
  <cosponsors>
    <cosponsor bioguide_id="B001267" joined="2018-09-27"/>
  </cosponsors>
  <actions>
    <action datetime="2018-09-27">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-09-27" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-20T20:35:00Z" status="Introduced in Senate">Making Objective Drug Evidence Revisions for New Labeling Act or the MODERN Labeling Act

This bill amends the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with authority to require updates to drug labeling to reflect new information relevant to the drug and its use.</summary>
</bill>
